Outbreak response strategies with type 2-containing oral poliovirus vaccines
Open Access
- 17 November 2022
- Vol. 41 (Suppl 1) , A142-A152
Abstract
No abstract availableKeywords
Funding Information
- Centers for Disease Control and Prevention
This publication has 46 references indexed in Scilit:
- Managing population immunity to reduce or eliminate the risks of circulation following the importation of poliovirusesVaccine, 2015
- Modeling the Potential Role of Inactivated Poliovirus Vaccine to Manage the Risks of Oral Poliovirus Vaccine CessationThe Journal of Infectious Diseases, 2014
- Poliovirus vaccination options for achieving eradication and securing the endgameCurrent Opinion in Virology, 2013
- Oral Poliovirus Vaccine Evolution and Insights Relevant to Modeling the Risks of Circulating Vaccine‐Derived Polioviruses (cVDPVs)Risk Analysis, 2013
- Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessationExpert Review of Vaccines, 2012
- Optimal vaccine stockpile design for an eradicated disease: Application to polioVaccine, 2010
- Evaluation of Response Scenarios to Potential Polio Outbreaks Using Mathematical ModelsRisk Analysis, 2006
- Risks of Paralytic Disease Due to Wild or Vaccine‐Derived Poliovirus After EradicationRisk Analysis, 2006
- Retrospective Cost‐Effectiveness Analyses for Polio Vaccination in the United StatesRisk Analysis, 2006
- Rational Design of Genetically Stable, Live-Attenuated Poliovirus Vaccines of All Three Serotypes: Relevance to Poliomyelitis EradicationJournal of Virology, 2006